The present study focuses on the establishment and characterization of a ne
w follicular thyroid carcinoma cell line. The human cell line ML-1 was deri
ved from a dedifferentiated follicular thyroid carcinoma relapse, which pro
gressed despite preceding surgery followed by two radioiodine therapies. Mo
re than 90% of the cells of this line express thyroglobulin? chondroitin su
lfate, and vimentin antigens, but only about 70% show cytokeratin filaments
and a negative surface charge density such as human erythrocytes. More imp
ortantly, cells of this line are able to take up iodine and/or glucose both
in vitro and in vivo and to secrete thyroglobulin, chondroitin sulfate, an
d fibronectin into the interstitial space. In addition, triiodothyronine is
released constitutively into culture supernatants. Moreover, it is also su
itable for xenotransplantation studies because it is tumorigenic in NMRI nu
de mice in vivo. The cell line forms tumors with follicular structures when
transplanted to nude mice. Due to these unique features the ML-I cell line
can be considered as a very suitable test model for pharmacological and ce
ll biological studies. Since chemicals may interfere with the production of
thyroid hormones, this cell line represents also a tool for toxicological
investigations.